AZN News and Press, AstraZeneca PLC From 01/11/24

2024-01-11 11:19:54 ET More on Cytokinetics Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upgrade) Cytokinetics: Buyout Rumors Ahead Of The Key Phase 3 Readout Of Aficamten Cytokinetics, Incorporated (CYTK) Q3 2023 Earnings Call Transcript ...

2024-01-11 08:42:53 ET Summary Innate Pharma is a European biotech specializing in the development of immunotherapeutics for various cancer types. Their most advanced projects focus on engaging and activating natural killer cells, with promising results in clinical trials. The...

2024-01-10 05:54:35 ET Daiichi Sankyo ( OTCPK:DSNKY ) has reportedly filed for regulatory approval for a cancer treatment it is co-developing with AstraZeneca ( NASDAQ: AZN ). According to a report by Citi analysts, the Japanese drugmaker confirmed during a recent investor e...

2024-01-09 18:04:24 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...

2024-01-09 04:33:26 ET More on GSK GSK - Greenshoots In The Horizon Getting_Ahead_of_Respiratory_Diseases_Slides GSK, Teva, AstraZeneca under Senate probe over asthma inhaler pricing For further details see: GSK to buy Aiolos Bio for up to $1.4B to expand...

2024-01-08 15:45:47 ET More on AstraZeneca, GSK, etc. Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win AbbVie Vs. GSK: Dual Dominance In Pharma GSK - Greenshoots In The Horizon FDA evaluating reports of GLP-1 drugs and negative side effects ...

2024-01-08 12:53:29 ET Summary Large pharma stocks, including Johnson & Johnson, may be experiencing a shift in favor as investors move away from glamour growth stocks as 2024 gets underway. Johnson & Johnson is a leading global healthcare company with a below-market valua...

2024-01-08 12:10:53 ET More on Cytokinetics Cytokinetics: Clear Win For Aficamten In SEQUOIA-HCM Phase 3 Trial (Upgrade) Cytokinetics: Buyout Rumors Ahead Of The Key Phase 3 Readout Of Aficamten Cytokinetics, Incorporated (CYTK) Q3 2023 Earnings Call Transcript ...

2024-01-08 08:30:08 ET NetworkNewsWire Editorial Coverage New York, NY – January 8, 2024 – Already proven to be a revolutionary treatment for type 2 diabetes and weight loss, glucagon-like peptide-1 (GLP-1) agonists now appear to have a multitude of potential b...

Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer PR Newswire HOLON, Israel , Jan. 8, 2024 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinica...